Tag | Content |
---|
EnhancerAtlas ID | HS109-15889 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr3:128947670-128948570 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
JUN(var.2) | MA0489.1 | chr3:128948209-128948223 | AAGAGGTGACTCAG | + | 6.18 | NFE2L1 | MA0089.2 | chr3:128948212-128948227 | AGGTGACTCAGCAGG | + | 6.09 | Nfe2l2 | MA0150.2 | chr3:128948210-128948225 | AGAGGTGACTCAGCA | + | 6.01 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_00351 | chr3:128942710-128948804 | Adipose_Nuclei | SE_09351 | chr3:128942211-128955342 | CD14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I129223 | chr3 | 128942638 | 128954642 |
|
Enhancer Sequence | CTGGCACGGT GTCAGGCACA GTGGAAAAGG CCCTAAGTGA ATGTTGTGTG ATAATTTCCT 60 AGGAGTCCTC ACTCTTGTGG ACACTGCATT CCCAGGCTCC CTTGCCAATT GTCTTAGGCC 120 GGGGCCAGCC GCTGGGAGAT GCATGTGGGA GACTGGTGGC TTGGGGGAGG GAGAAACCAG 180 GGTATTTCTC CCTTTCTCCC TCTGCCTGGG GTGGGACGGC AACTAATTCT CCTCTGAATA 240 CTGGTTCCCA GTAGGACAGC CCCTCTCTCT GTGGCTGCAG TGCCCACCAG GTGGCCCTCA 300 TCACGACCTT GGTTCCCACA GATGGCTCCA GCTGCTGGGC TCCACTTCCA CCTCTACCCT 360 AGAGGCAAGA GAGGCTTCCT GTCCTTCCTG TTGCTGATCT CCCAGTTCCC TCCCCACTTC 420 CTGCTTGGTT TCCCAGCTCT TCCATTCCTG TGTAATAAGT CCTTGTACTG AATTCTGTCT 480 GCTTCTGCCT GGGCTGTGGC TGATACACAC GGTAATTGTT CAGACTAAGC TATGCAGTAA 540 AGAGGTGACT CAGCAGGCTT GTGACGCTCA AACCCTGCAC ATCCCAAAGA CCGGCTCCTG 600 GAAGATAACC TATAAACAGT TGAAATATCC TGCCTGATGG AGTGGCTTTG CATACCTGGG 660 GCCTTGGGCC CTGCCAGATA CTTGTGCTAA AAATGTGCTT CGGGGTGAAT GTCCGTTTCT 720 GTTTGCTTCG GGTCTTGGGC CACACTGAGT TTGACGTGGT TGCAGGGTCA TGCTGGAGAC 780 TAAGATCAAG CAGGTTGGTG CTCCATGGCC GTGTGACTGA CCCTCAATAA AAAACCTGCA 840 CACTGAGGCT TGGGTGAGCT TCCCTGTTGT CAACACTCCC TGCAGGCTAC CACGCATCCT 900
|